An independent laboratory has found that BIOGUARD barrier gauze dressings with Quick-Med's novel NIMBUS antimicrobial technology exhibit high antiviral efficacy against the H1N1 virus.

Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that The Wall Street Transcript (TWST) has included an interview with the Company's CEO, J. Ladd Greeno, in the publication's latest Pharmaceutical Report.

Quick-Med, a pioneer in advanced antimicrobial technologies for medical and consumer applications, announced today that USPTO and the World Intellectual Property Organization have published Company patent applications covering Disinfectant Alcohol-Soluble Quaternary Ammonium Polymers.

Summit Corporate Services has secured a new facility to accommodate its growing client base and expanding service offerings.

Summit Corporate Services to provide customer service, order processing & fulfillment, product support, inventory management, distribution, invoicing, collections and logistical support for Mederi Therapeutics' Stretta and Secca product lines.

EuroMed Inc., a leading developer and manufacturer of wound care management products, has added a new product to its SureSkin line of hydrocolloid dressings, and in doing so, has launched a new offensive against chronic and acute wounds.

EuroMed, Inc., currently located in Northvale, NJ, plans to relocate to Orangeburg, NY.

EuroMed Inc. honored by Medical Device and Diagnostic Industry Magazine (MD&DI) with a Medical Design Excellence Award (MDEA).